Robert Glassman

Robert H.
Glassman currently works at Pharvaris NV, as Independent Non-Executive Director from 2021, Tarus Therapeutics, Inc., as Independent Director from 2021, Jubilant Therapeutics, Inc., as Independent Non-Executive Director from 2021, Umoja Biopharma, Inc., as Director from 2021, Pharvaris GmbH, as Director from 2021, Weill Cornell Medical College, as Clinical Assistant Professor, and Enavate Sciences, as Executive Vice President-Search & Evaluation from 2022.
Dr. Glassman also formerly worked at Credit Suisse Securities (USA) LLC, as Vice Chairman & Managing Director from 2015 to 2021, Bank of America Merrill Lynch (New York), as Managing Director from 2010 to 2015, Portage Biotech, Inc., as Independent Director from 2022 to 2024, Merrill Lynch & Co., Inc., as Principal in 2008, McKinsey & Co., Inc., as Consultant, The Rockefeller University, as Basic Science Investigator, and OrbiMed Advisors Private Equity, as Partner from 2009 to 2010.
Dr. Glassman received his doctorate degree from Harvard Medical School and undergraduate degree from Harvard College.